Figure 4 | Scientific Reports

Figure 4

From: Evaluation of nimotuzumab Fab2 as an optical imaging agent in EGFR positive cancers

Figure 4

Optical imaging of IRDye800CW-labled nimotuzumab Fab2 in A-431 xenografts. Mice bearing A-431 xenografts were injected with IRDye800CW-labeled nimotuzumab Fab2 and imaged over time. (a) Dorsal and ventral mouse images taken over time. X = xenograft, B = bladder, L = liver, K = kidney. (b) Normalized signal of xenograft, kidney, liver and contralateral over time. (c) Tumor-to-background ratio (TBR) in the xenograft over time.

Back to article page